Literature DB >> 9674856

Oligoclonal dominance of immunoglobulin VH3 rearrangements following allogeneic bone marrow transplantation.

I Näsman-Björk1, I Lundkvist.   

Abstract

Normal numbers of circulating B lymphocytes are reached during the first 6 months following allogeneic BMT, but humoral immunity remains poor. The molecular basis for this lack of function in the first appearing B lymphocytes has not been clarified. Accordingly, we have studied the reconstitution of the VH3 containing Ig repertoire in two CML patients transplanted with allogeneic BM and one healthy control. PBMCs were isolated at several time-points after BMT and mRNA was prepared. VH3 containing Ig rearrangements were amplified with RT-PCR and then cloned and analyzed with colony hybridization using complementary determining region 3 (CDR3)-specific oligonucleotide probes. Four weeks after BMT, two individual clones together represented 52% of the analyzed CDR3 regions. At 6, 8 and 12 weeks after BMT the corresponding probes hybridized with 2-6% of the colonies. A similar pattern was obtained for the other patient. In samples from the healthy control no clones were detected using CDR3-specific oligonucleotide probes from the control. We conclude that the VH3 containing Ig repertoire after BMT is oligoclonal and that specific rearrangements dominate at different time-points. This restriction of the B cell repertoire may contribute to the impaired humoral immunity observed in BMT recipients.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9674856     DOI: 10.1038/sj.bmt.1701261

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  6 in total

1.  Memory B lymphocytes determine repertoire oligoclonality early after haematopoietic stem cell transplantation.

Authors:  B Omazic; I Lundkvist; J Mattsson; J Permert; I Nasman-Bjork
Journal:  Clin Exp Immunol       Date:  2003-10       Impact factor: 4.330

2.  A human monoclonal antibody drug and target discovery platform for B-cell chronic lymphocytic leukemia based on allogeneic hematopoietic stem cell transplantation and phage display.

Authors:  Sivasubramanian Baskar; Jessica M Suschak; Ivan Samija; Ramaprasad Srinivasan; Richard W Childs; Steven Z Pavletic; Michael R Bishop; Christoph Rader
Journal:  Blood       Date:  2009-08-10       Impact factor: 22.113

3.  Long-term persistence of oligoclonal serum IgM repertoires in patients treated with allogeneic bone marrow transplantation (BMT).

Authors:  I N Björk; C Brissac; M Remberger; J Mattsson; S Klaesson; O Ringdén; J Stewart; I Lundkvist
Journal:  Clin Exp Immunol       Date:  2000-01       Impact factor: 4.330

Review 4.  B cells and transplantation: an educational resource.

Authors:  Trudy N Small; William H Robinson; David B Miklos
Journal:  Biol Blood Marrow Transplant       Date:  2009-01       Impact factor: 5.742

Review 5.  Immune Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Justyna Ogonek; Mateja Kralj Juric; Sakhila Ghimire; Pavankumar Reddy Varanasi; Ernst Holler; Hildegard Greinix; Eva Weissinger
Journal:  Front Immunol       Date:  2016-11-17       Impact factor: 7.561

Review 6.  Mass Cytometry for the Assessment of Immune Reconstitution After Hematopoietic Stem Cell Transplantation.

Authors:  Lauren Stern; Helen McGuire; Selmir Avdic; Simone Rizzetto; Barbara Fazekas de St Groth; Fabio Luciani; Barry Slobedman; Emily Blyth
Journal:  Front Immunol       Date:  2018-07-26       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.